METTLER TOLEDO is proud to announce that its Rainin TerraRack™ line of pipette tip racks has achieved success in this year’s Green Apple Awards.
The judges clearly recognised the environmental benefits of this innovative product range – which is designed to minimise the problem of plastic tip rack waste – selecting TerraRack from a field of more than 500 entries to receive a Bronze Award for Environmental Best Practice. The award was presented to EU Market Manager Ian Eaton-Taylor at a ceremony held at the Houses of Parliament in London on Monday November 16th...
Asynt announces that Rapid Powders Ltd. (Stoke-on-Trent, UK) has been using a PressureSyn High Pressure Reactor to undertake series of process experiments using small amounts of precious materials to produce optimally functionalised polymers.
Rapid Powders Limited specialise in producing polymers with dispersions of functional materials such as metals, ceramics and carbons. Applications for these specialist materials include packaging, electrically conducting polymers, thermally conducting polymers and pigments. To enable them to rapidly make small batches of these functionalised polymers, Rapid Polymers Ltd evaluated various commercial small volume high pressure reactors for safety...
Chromatrap®, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious “Epigenetics in Drug Discovery” conference to be held in Cambridge, UK from 26th-27th January 2016.
Viewed as a new frontier in drug discovery, rapid progress has been made in enhancing understanding of epigenetic mechanisms of both new and existing drugs. With the processes that control epigenomic function providing new opportunities, epigenetics targets are enabling the discovery of novel drugs. At the conference - Dr Amy Beynon will deliver a presentation highlighting the use of new Chromatrap solid state ChIP...
Analytik, leading suppliers of innovative analytical instrumentation, announce their new social media channels.
Analytik’s social media presence has quickly evolved from an experimental marketing approach to become an essential tool, central to our future growth and development strategy. Social media channels allow Analytik to maintain real-time connections with our customers and show the more personalised and human elements of our services. Social media is about engaging with an online audience and sharing relevant, interesting and...
Fedor Jelezko and Jörg Wrachtrup are the winners of the prestigious ZEISS Research Award in 2016.
They have been honored for their outstanding work on quantum technology with optically addressable spins in diamond. The award will be presented within the framework of the ZEISS Symposium that will take place for the first time on 23 June 2016 in the ZEISS Forum in Oberkochen. During this event international experts will conduct discussions and identify trends and requirements in the fields of optics and photonics that are being strongly influenced and changed by the...
Syrris, a world leader in flow product innovation, has been a driving force in enhancing R&D chemistry productivity ever since the company’s foundation 14 years ago.
This achievement is amply recognised by the wealth of impressive publications describing novel flow chemistry applications developed using Syrris reactors. Today, scientists have access to hundreds of flow chemistry papers citing groundbreaking applications established on modular reactors from Syrris, including the Ley group’s Accelerating Spirocyclic Polyketide Synthesis using Flow Chemistry1. The group, based at the University...
India’s largest employment sector focuses on enhancing consumer safety
Seward Ltd., manufacturer of the original Stomacher® laboratory paddle blenders and accessories used in sample preparation for microbiological analysis, announces that its Technical Director, Stuart Ray, has recently presented as an invited speaker at a prestigious food safety conference. The 10th National Food Safety and Quality Summit, organised by the Confederation of Indian Industry (CII) in New Delhi, focused on ‘Integrating Global...
Medical technology company benefits from currency effects / Earnings impacted by special effects
Carl Zeiss Meditec AG looks back on another positive fiscal year: boosted by positive currency effects, the medical technology company's revenue passed the billion mark in fiscal year 2014/15, with a 14 percent increase to € 1,040 million. Adjusted for currency effects, this equates to growth of around 8 percent over the prior year. Earnings before interest and taxes (EBIT) increased by 8 percent, to € 130.6 million (prior year: € 120.7 million)...
Illumina invests in Desktop Genetics’ technology to support the platform’s integration with NGS pipelines and improve CRISPR genome editing workflows
Desktop Genetics Ltd (“DTG” or “the Company”), a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding from Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing (NGS) technology. The investment will be used to fund the continued development and commercialization of the DESKGEN platform with a particular focus on integration with NGS pipelines. The investment from Illumina follows DTG’s recent fundraising from a syndicate of...
The Genome Analysis Centre (TGAC) is delighted to announce the appointment of Professor Neil Hall as its new Director.
Professor Neil Hall will join TGAC in April 2016 from the University of Liverpool where he is currently the Director of The Centre for Genomic Research. As a leader in the field of genomics, Professor Hall has specialised in understanding the genomics of infectious disease over the past decade. He has led projects at The Wellcome Trust Sanger Institute and The Institute for Genomic Research (TIGR) in the US, including the effort to
One World Lab has announced a strategic partnership with Tonbo Biosciences meaning a complete offering of primary antibodies in a conjugated format are now available at www.oneworldlab.com.
Researchers now have access to a full resource of flow cytometry antibodies that are manufactured to the highest quality and precision, resulting in consistently high performance. In line with the One World Lab model, these antibodies are offered in test sized aliquots allowing researchers the flexibility to test multiple antibodies more cost efficiently. Conjugated primary antibodies are extremely useful reagents for studies in a number of...
The European Investment Bank, Europe’s long-term lending institution, has agreed to provide GBP 107m to support construction of the new Midland Metropolitan Hospital in Birmingham.
Once open in three years’ time the brand new hospital will provide state of the art acute healthcare for 530,000 people living in Sandwell and West Birmingham and include one of the largest accident and emergency departments in Europe. The new hospital scheme, costing GBP 340m, includes 670 beds and 15 operating theatres, as well as a new public park, reached financial close following an agreement between the Sandwell...
The University of Nottingham, a long-standing customer of UK flowmeter specialist Litre Meter, has ordered further Smart-Trak high-performance digital mass flow controllers to measure the flow of gases used in biomolecular research.
The latest order forms part of a supply relationship between Litre Meter and the Centre for Biomolecular Sciences at the University of Nottingham (CBS) dating back more than 20 years. During that time Litre Meter has supplied various flowmeters for a number of research applications and undertaken calibration services as required. Litre Meter has most recently supplied a range of Smart-Trak? 100 Series instruments designed to measure flow ranges...
The latest software release along with an expansion of the global technical specialist team, highlight Malvern Instruments’ ongoing commitment to extending and supporting the application of NanoSight, a nanoparticle characterization technology with unique capabilities.
The Malvern NanoSight range enables the visualization, sizing and counting of nanoparticles, exosomes, protein aggregates, and is increasingly being used in biopharma and nanoparticle research. “Two years on from joining Malvern, the benefits of becoming part of a larger global business are clear. NanoSight customers are now benefiting directly from Malvern’s highly developed skills in making complex analytical techniques more...
EU study to build on Phase I trial of Videregen product & generate approval application
The pan-European TETRA consortium, led by Videregen Limited, has been awarded EUR 6.8 million under the Horizon 2020 programme[1] for a pivotal Phase II clinical trial of the company's tissue engineered replacement trachea. The project will start at the beginning of 2016 with the first patients to be treated in 2017, building on the results of the four-patient UK INSPIRE Phase I study[2] The study will focus on the orphan indication...
The company aims to advance NOSO-95179, a promising antibacterial compound, to clinical stage for the treatment of multidrug-resistant Gram-negative infections
Nosopharm, a biotechnology company specialized in the research and development of new antibacterial molecules, today announces it has been selected to join ENABLE (European Gram-negative Antibacterial Engine), a project working to advance the development of potential antibiotics against multidrug resistant Gram-negative infections. ENABLE is one of seven projects in the New Drugs For Bad Bugs (ND4BB) consortium, part of the Innovative Medicines...
Demand drives expansion of Titian's team, underlining the global success of its Mosaic software
Titian Software, has announced the appointments of James Craven, head of global marketing, and Angela Gray, Western US sales manager, to further consolidate its position as the world leader in sample management software. The successful launch earlier this year of Titian’s Mosaic Freezer Management, a cost-effective software package optimised for small to medium-sized sample collections, followed the recent introduction of Titian’s Mosaic...
NHS Wales Shared Services Partnership, on behalf of Betsi Cadwaladr University Local Health Board, contracted with Leica Biosystems for its Aperio digital pathology solutions.
This partnership has enabled the merging of three sites: Glan Clwyd, Wrexham & Bangor to form the new trust: North Wales. Digital pathology enables rapid distribution, eliminating slide shipping costs and travel time. Additionally, the digital slides can be annotated to facilitate a more efficient and accurate review from one pathologist to another. The use of digital pathology is leveraging NHS Wales as a pioneering healthcare organization...
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will join the MATURA Consortium.
The overarching mission of the MATURA Consortium is to improve patient care in Rheumatoid Arthritis (RA) by rationalizing therapy decisions through a stratified medicine approach.
MATURA (MAximising Therapeutic Utility for Rheumatoid Arthritis) aims to identify treatment response predictors which will allow the allocation of patients to subgroups defined by the therapy they are most likely to respond to, early in the disease process. RA provides the ideal setting for the introduction of a stratified medicine approach as the treatment is standardized, there is a significant non-responder rate to each marketed and commonly used drug, and early and effective therapy has consistently been shown to improve long-term outcomes, including joint damage, disability and employment.
Acquisition increases capacity to deliver high quality, locally manufactured oligos.
Integrated DNA Technologies, the global leader in custom nucleic acid synthesis, has entered into a definitive agreement to acquire the oligonucleotide synthesis business of AITbiotechPte. Ltd. in Singapore (“AITbiotech”). With this acquisition, IDT expands its customer base across Southeast Asia making it possible for these additional customers to now have access to its broad range of products for genomic applications. AITbiotech will...
Quotient Clinical the Translational Pharmaceutics® company, has announced that it has been acquired by specialist healthcare investor GHO Capital, with financial details of the transaction remaining undisclosed.
Quotient Clinical has brought innovation to the drug development process through its unique Translational Pharmaceutics® platform, which integrates formulation development, real-time GMP manufacturing and clinical testing. This approach has been proven to accelerate timelines and reduce associated costs, driving overall improvements in R&D productivity. With over 280 employees, the company serves an international customer...